X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (103497) 103497
Newsletter (14689) 14689
Book Review (13694) 13694
Publication (8566) 8566
Newspaper Article (4847) 4847
Book Chapter (881) 881
Conference Proceeding (789) 789
Dissertation (266) 266
Government Document (147) 147
Magazine Article (100) 100
Web Resource (72) 72
Trade Publication Article (49) 49
Reference (46) 46
Book / eBook (26) 26
Data Set (8) 8
Transcript (6) 6
Streaming Video (5) 5
Paper (4) 4
Journal / eJournal (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (80301) 80301
humans (58762) 58762
epidermal growth factor (50244) 50244
animals (37243) 37243
female (25245) 25245
oncology (24371) 24371
cancer (21713) 21713
research (20362) 20362
male (18754) 18754
mice (16850) 16850
receptor, epidermal growth factor - metabolism (15342) 15342
cell biology (14415) 14415
biochemistry & molecular biology (14250) 14250
expression (13008) 13008
middle aged (11784) 11784
signal transduction (11456) 11456
mutation (11214) 11214
epidermal growth factor - pharmacology (11161) 11161
epidermal-growth-factor (10688) 10688
receptor, epidermal growth factor - genetics (10637) 10637
phosphorylation (10418) 10418
proteins (10394) 10394
aged (9775) 9775
adult (9761) 9761
analysis (9509) 9509
epidermal growth-factor (9420) 9420
cell line, tumor (9308) 9308
cells, cultured (9219) 9219
rats (9166) 9166
genetic aspects (8970) 8970
care and treatment (8927) 8927
tumors (8670) 8670
breast cancer (8239) 8239
receptor, epidermal growth factor - antagonists & inhibitors (8019) 8019
epidermal growth factor receptor (7874) 7874
gene expression (7848) 7848
chemotherapy (7765) 7765
lung cancer (7359) 7359
kinases (7344) 7344
immunohistochemistry (7325) 7325
metastasis (7184) 7184
egfr (7080) 7080
epidermal growth factor receptors (7037) 7037
cell line (6982) 6982
apoptosis (6911) 6911
growth-factor receptor (6910) 6910
cells (6828) 6828
epidermal growth factor - metabolism (6639) 6639
reports (6408) 6408
prognosis (6312) 6312
activation (6113) 6113
lung cancer, non-small cell (5764) 5764
tyrosine (5703) 5703
oncology, experimental (5696) 5696
health aspects (5691) 5691
gefitinib (5309) 5309
physiological aspects (5274) 5274
multidisciplinary sciences (5059) 5059
article (4996) 4996
antineoplastic agents - therapeutic use (4857) 4857
medicine (4819) 4819
cell proliferation (4809) 4809
research article (4803) 4803
molecular sequence data (4763) 4763
cancer therapies (4662) 4662
tumor cells, cultured (4558) 4558
aged, 80 and over (4460) 4460
pharmacology & pharmacy (4455) 4455
lung neoplasms - genetics (4447) 4447
lung neoplasms - drug therapy (4441) 4441
universities and colleges (4225) 4225
therapy (4198) 4198
abridged index medicus (4173) 4173
patients (4119) 4119
survival (4040) 4040
biochemistry (4036) 4036
medical research (4019) 4019
signal transduction - drug effects (4009) 4009
growth factors (3978) 3978
gene-expression (3962) 3962
development and progression (3944) 3944
proliferation (3894) 3894
amino acid sequence (3885) 3885
pathology (3871) 3871
protein (3848) 3848
antineoplastic agents - pharmacology (3842) 3842
genes (3841) 3841
factor receptor (3825) 3825
in-vitro (3824) 3824
growth (3780) 3780
rodents (3729) 3729
differentiation (3679) 3679
carcinoma (3672) 3672
cell division - drug effects (3667) 3667
carcinoma, non-small-cell lung - drug therapy (3660) 3660
receptor (3644) 3644
time factors (3622) 3622
lung neoplasms - pathology (3598) 3598
ligands (3586) 3586
surgery (3560) 3560
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (120569) 120569
Chinese (1306) 1306
Japanese (694) 694
French (496) 496
German (370) 370
Russian (314) 314
Spanish (221) 221
Korean (193) 193
Polish (89) 89
Hungarian (47) 47
Italian (43) 43
Portuguese (35) 35
Czech (31) 31
Turkish (29) 29
Dutch (12) 12
Bulgarian (11) 11
Danish (9) 9
Croatian (7) 7
Hebrew (7) 7
Ukrainian (7) 7
Persian (6) 6
Finnish (4) 4
Norwegian (4) 4
Romanian (4) 4
Swedish (4) 4
Lithuanian (3) 3
Serbian (2) 2
Slovak (2) 2
Catalan (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2006, Methods in molecular biology, ISBN 1588294218, Volume 327., xi, 208
Book
1990, ISBN 9780121531249, Volume 24., xv, 347
Book
The New England Journal of Medicine, ISSN 0028-4793, 09/2009, Volume 361, Issue 10, pp. 958 - 967
Journal Article
1981, ISBN 9783540106234, Volume 57., xxii, 630
Book
Oncogene, ISSN 0950-9232, 12/2010, Volume 29, Issue 49, pp. 6485 - 6498
Journal Article
Archives of Pathology and Laboratory Medicine, ISSN 0003-9985, 02/2014, Volume 138, Issue 2, pp. 241 - 256
Journal Article
Journal Article
Nature Medicine, ISSN 1078-8956, 03/2016, Volume 22, Issue 3, pp. 262 - 269
Journal Article
Nature, ISSN 0028-0836, 2014, Volume 506, Issue 7487, pp. 230 - 234
There are no clinically relevant treatments available that improve function in the growing population of very preterm infants (less than 32 weeks' gestation)... 
MULTIPLE-SCLEROSIS | LOW-BIRTH-WEIGHT | OLIGODENDROCYTE PROGENITORS | MULTIDISCIPLINARY SCIENCES | HYPOXIC INJURY | CENTRAL-NERVOUS-SYSTEM | MOUSE CORPUS-CALLOSUM | PRETERM INFANTS | RAT-BRAIN | WHITE-MATTER ABNORMALITIES | FACTOR RECEPTOR | Epidermal Growth Factor - administration & dosage | Oligodendroglia - metabolism | Receptor, Epidermal Growth Factor - genetics | Demyelinating Diseases - congenital | Brain Injuries - drug therapy | Humans | Brain Injuries - congenital | Male | Stem Cells - cytology | Demyelinating Diseases - metabolism | Epidermal Growth Factor - therapeutic use | Molecular Targeted Therapy | Stem Cells - metabolism | Cell Lineage - drug effects | Hypoxia - metabolism | Receptor, Epidermal Growth Factor - metabolism | Oligodendroglia - drug effects | Time Factors | Oligodendroglia - cytology | Demyelinating Diseases - pathology | Disease Models, Animal | Animals, Newborn | Cell Survival - drug effects | Demyelinating Diseases - prevention & control | Administration, Intranasal | Infant, Premature, Diseases - drug therapy | Cell Division - drug effects | Brain Injuries - prevention & control | Oligodendroglia - pathology | Hypoxia - genetics | Regeneration - drug effects | Animals | Signal Transduction - drug effects | Cell Differentiation - drug effects | Hypoxia - pathology | Stem Cells - drug effects | Hypoxia - physiopathology | Infant, Premature, Diseases - metabolism | Mice | Epidermal Growth Factor - pharmacology | Brain Injuries - pathology | Infant, Premature, Diseases - pathology | Brain | Medical research | Care and treatment | Infants (Premature) | Risk factors | Complications and side effects | Epidermal growth factor | Physiological aspects | Medicine, Experimental | Hypoxia | Diagnosis | Health aspects | Injuries | Attention deficit disorder | Brain damage | Rodents | Apoptosis | Index Medicus
Journal Article
Nature, ISSN 0028-0836, 07/2012, Volume 487, Issue 7408, pp. 505 - 509
Mutationally activated kinases define a clinically validated class of targets for cancer drug therapy(1). However, the efficacy of kinase inhibitors in... 
CELL LUNG-CANCER | SURVIVAL | HETEROGENEITY | ACTIVATION | RECEPTOR TYROSINE KINASES | THERAPY | MET AMPLIFICATION | MULTIDISCIPLINARY SCIENCES | ACQUIRED-RESISTANCE | SENSITIVITY | TUMOR-CELLS | Receptor, ErbB-2 - genetics | Humans | Receptor, ErbB-2 - metabolism | Melanoma - enzymology | Phosphatidylinositol 3-Kinases - metabolism | Hepatocyte Growth Factor - pharmacology | Breast Neoplasms - metabolism | Melanoma - genetics | Female | Indoles - pharmacology | Antineoplastic Agents - pharmacology | Cell Survival - drug effects | Melanoma - pathology | Receptor Protein-Tyrosine Kinases - metabolism | Sulfonamides - pharmacology | Breast Neoplasms - drug therapy | Hepatocyte Growth Factor - metabolism | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Breast Neoplasms - genetics | Signal Transduction - drug effects | Breast Neoplasms - pathology | Proto-Oncogene Proteins B-raf - genetics | Melanoma - drug therapy | Cell Line, Tumor | Ligands | Protein Kinase Inhibitors - pharmacology | Quinazolines - pharmacology | Drug Resistance, Neoplasm - drug effects | Mitogen-Activated Protein Kinases - metabolism | Antimitotic agents | Physiological aspects | Antineoplastic agents | Growth factors | Health aspects | Phosphotransferases | Substance abuse treatment | Epidermal growth factor | Rodents | Biomarkers | Breast cancer | Insulin-like growth factors | Kinases | Drug resistance | Tumors | Index Medicus
Journal Article